Scott S. Emerson

16.8k total citations · 8 hit papers
154 papers, 11.3k citations indexed

About

Scott S. Emerson is a scholar working on Statistics and Probability, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Scott S. Emerson has authored 154 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Statistics and Probability, 29 papers in Molecular Biology and 24 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Scott S. Emerson's work include Statistical Methods in Clinical Trials (42 papers), Diabetes Treatment and Management (22 papers) and Advanced Causal Inference Techniques (20 papers). Scott S. Emerson is often cited by papers focused on Statistical Methods in Clinical Trials (42 papers), Diabetes Treatment and Management (22 papers) and Advanced Causal Inference Techniques (20 papers). Scott S. Emerson collaborates with scholars based in United States, Canada and United Kingdom. Scott S. Emerson's co-authors include Paula Diehr, Thomas Lumley, Lu Chen, Thomas R. Fleming, Thomas D. Koepsell, Robert L. Carithers, John Deanfield, A. Michael Lincoff, Steven E. Kahn and Ildiko Lingvay and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Scott S. Emerson

150 papers receiving 10.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

2023 1.3k citations A. Michael Lincoff, Kirstine Brown‐Frandsen et al. New England Journal of Medicine profile →
The Importance of the Normality Assumption in Large Public Health Data Sets

2002 1.3k citations Scott S. Emerson et al. profile →
The Prevention and Treatment of Missing Data in Clinical Trials

2012 1.2k citations Scott S. Emerson et al. New England Journal of Medicine profile →
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

2017 409 citations Steven P. Marso, Darren K. McGuire et al. New England Journal of Medicine profile →
Evaluation of Aducanumab for Alzheimer Disease

2021 167 citations Scott S. Emerson et al. profile →
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

2024 123 citations John Deanfield, Scott S. Emerson et al. profile →
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

2024 100 citations John Deanfield, Steven E. Kahn et al. profile →
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes

2025 89 citations Darren K. McGuire, Nikolaus Marx et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Scott S. Emerson

Since Specialization

Citations

This map shows the geographic impact of Scott S. Emerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott S. Emerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott S. Emerson more than expected).

Fields of papers citing papers by Scott S. Emerson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott S. Emerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott S. Emerson. The network helps show where Scott S. Emerson may publish in the future.

Co-authorship network of co-authors of Scott S. Emerson

This figure shows the co-authorship network connecting the top 25 collaborators of Scott S. Emerson. A scholar is included among the top collaborators of Scott S. Emerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott S. Emerson. Scott S. Emerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes 2025 ·Advances in Therapy ·(unknown), (unknown), Ruben Vale, Scott S. Emerson, (unknown), Jorge Plutzky, Geraint Roberts, (unknown), A. Michael Lincoff	2
2	Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials 2025 ·Diabetes Care ·Matthew M.Y. Lee, Naveed Sattar, Rodica Pop‐Busui, John Deanfield, Scott S. Emerson, Silvio E. Inzucchi, Johannes F.E. Mann, Nikolaus Marx, Sharon L. Mulvagh, Neil R Poulter, Sunil V. Badve, Richard E. Pratley, Vlado Perkovic, John B. Buse, Darren K. McGuire, (unknown)	12
3	Semaglutide and cardiovascular outcomes in patients with overweight or obesity who do not have diabetes 2024 ·Obesity Research & Clinical Practice ·(unknown), (unknown), Kirstine Brown‐Frandsen, Helen M. Colhoun, John Deanfield, Scott S. Emerson, Sille Esbjerg, Søren Hardt‐Lindberg, G. Kees Hovingh, Steven E. Kahn, Robert F. Kushner, Ildiko Lingvay, Tuğçe Kalaycı Oral, Marie Mide Michelsen, Jorge Plutzky, Christoffer W. Tornøe, Donna H. Ryan	1
4	Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial 2024 ·Atherosclerosis ·Jorge Plutzky, Paweł Bogdański, Selçuk Dağdelen, John Deanfield, Scott S. Emerson, G. Kees Hovingh, Steven E. Kahn, (unknown), Gustavs Latkovskis, Michael Lehrke, Søren Hardt‐Lindberg, Ildiko Lingvay, Stephen C. Nicholls, Tuğçe Kalaycı Oral, (unknown), (unknown), Paul M. Ridker, Donna H. Ryan, A. Michael Lincoff	1
5	Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial 2022 ·Blood ·Terry Gernsheimer, Siobhan P. Brown, Darrell J. Triulzi, Nigel S. Key, Nahed El Kassar, Heather Herren, (unknown), Michael Boyiadzis, Brandi Reeves, (unknown), Monica B. Pagano, Scott S. Emerson, Susanne May	25
6	rigr: Regression, Inference, and General Data AnalysisTools in R 2022 ·The Journal of Open Source Software ·(unknown), Brian D. Williamson, (unknown), Charles J. Wolock, Andrew J. Spieker, (unknown), (unknown), Scott S. Emerson, Amy D. Willis	3
7	Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes breakdown → 2017 ·New England Journal of Medicine ·Steven P. Marso, Darren K. McGuire, Bernard Zinman, Neil R Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, (unknown), Martin Lange, Kirstine Brown‐Frandsen, Alan C. Moses, Simon Skibsted, Kajsa Kvist, John B. Buse	409
8	The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis 2016 ·PLoS ONE ·Stéphanie Kovacs, Anna Maria van Eijk, Esperança Sevene, Stephanie Dellicour, Noel S. Weiss, Scott S. Emerson, Richard W. Steketee, Feiko O. ter Kuile, Andy Stergachis	23
9	Detecting Differential Gene Expression in Subgroups of a Disease Population 2013 ·The International Journal of Biostatistics ·Sarah C. Emerson, Scott S. Emerson	1
10	A Critical Assessment of the Out-of-Hospital Trauma Triage Guidelines for Physiologic Abnormality 2010 ·The Journal of Trauma: Injury, Infection, and Critical Care ·Craig D. Newgard, Kyle Rudser, Jerris R. Hedges, Jeffrey D. Kerby, Ian G. Stiell, Daniel P. Davis, Laurie J. Morrison, Eileen M. Bulger, Thomas E. Terndrup, Joseph P. Minei, (unknown), Scott S. Emerson	43
11	Exploring the benefits of adaptive sequential designs in time‐to‐event endpoint settings 2010 ·Statistics in Medicine ·Sarah C. Emerson, Kyle Rudser, Scott S. Emerson	10
12	HIV Infection and Antiretroviral Therapy: Effect on Hepatitis C Virus Quasispecies Variability 2006 ·The Journal of Infectious Diseases ·Margaret C. Shuhart, Daniel G. Sullivan, (unknown), Robert Harrington, Mari M. Kitahata, T. L. Mathisen, (unknown), Scott S. Emerson, David R. Gretch	31
13	A Note on P‐Values under Group Sequential Testing and Nonproportional Hazards 2005 ·Biometrics ·Daniel L. Gillen, Scott S. Emerson	5
14	Soy Isoflavones Do Not Modulate Circulating Insulin-Like Growth Factor Concentrations in an Older Population in an Intervention Trial 2003 ·Journal of Nutrition ·Kenneth Adams, Katherine M. Newton, Chu Chen, Scott S. Emerson, John D. Potter, Emily White, Johanna W. Lampe	29
15	Risk of death among chronic dialysis patients infected with hepatitis C virus 1998 ·American Journal of Kidney Diseases ·C. Stehman-Breen, Scott S. Emerson, David R. Gretch, (unknown)	147
16	ASSOCIATION OF HEPATITIS C VIRUS INFECTION WITH MORTALITY AND GRAFT SURVIVAL IN KIDNEY-PANCREAS TRANSPLANT RECIPIENTS 1997 ·Transplantation ·Catherine Stehman‐Breen, Bruce M. Psaty, Scott S. Emerson, David R. Gretch, Mary P. Bronner, Christopher L. Marsh, Connie L. Davis	33
17	Statistical Packages for Group Sequential Methods 1996 ·The American Statistician ·Scott S. Emerson	12
18	Serum can inhibit reversal of multidrug resistance by chemosensitisers 1996 ·European Journal of Cancer ·M. Lehnert, Rita de Giuli, Kathleen Kunke, Scott S. Emerson, William S. Dalton, S. E. Salmon	23
19	Inhibition of prostaglandin synthesis: Potential for chemoprevention of human colon cancer 1991 ·David L. Earnest, Lee J. Hixson, (unknown), Scott S. Emerson, David S. Alberts	7
20	Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction 1990 ·Journal of the American College of Cardiology ·Jay Dinerman, Jawahar L. Mehta, Tom Saldeen, Scott S. Emerson, Rolf Wallin, Rajesh K. Davda, Andrew Davidson	154

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact